Topics and Expertise: CERSI

UCSF-Stanford CERSI Hosts Summit to Advance Regulatory Science and Health Care Innovation7

Tue Jan 21, 2025
five panel speakers seated on stage.
Holly Ly

Current and former FDA commissioners engage in the FDA Chiefs Chat at the CERSI Summit.

Leaders from the academic, industry and regulatory sectors engaged in thoughtful dialogue and addressed critical issues in regulatory science, health care and the development of medical products at the sixth annual UCSF-Stanford Centers of Excellence in Regulatory Science and Innovation (CERSI)...

School of Pharmacy leads in NIH funding for the 44th straight year8

Mon Mar 18, 2024
women in a laboratory discuss a project.
School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

UCSF-Stanford CERSI Hosts 2024 Summit of Regulatory Science Leaders9

Fri Mar 15, 2024
large room with audience engaged.
The fifth annual summit was UCSF-Stanford CERSI’s largest in-person meeting yet, showcasing the School’s commitment to the dynamic field of regulatory science in discussions with FDA center directors and past and present FDA commissioners.

A budding partnership with Korean regulatory science pharmacists10

Fri Sep 1, 2023
Giacomini and delegate.
Eric Davila
A delegation from South Korea visited to sign a Memorandum of Understand (MOU) initiating potential collaborations between UCSF and Korean schools of pharmacy.

Dozens of presumed inactive ingredients may impact human biology11

Wed Jul 29, 2020
Various pills
Morguefile.com

School scientists have found that various inactive ingredients in drugs, known as excipients, may produce unwanted side effects in the human body.

School scientists identify excipients with potential to cause side effects

FDA, academia, and industry join forces to shepherd new therapies to patients12

Thu Jan 23, 2020
Giacomini
Terrificshot13

Kathy Giacomini, PhD, is co-director of UCSF-Stanford CERSI.

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

USP/UCSF fellowship to support research in the quality and safety of medical products14

Wed Feb 27, 2019
Pharmaceutical drugs
© majedphoto.com15

The UCSF Fellowship in Quality of Medical Products will support research into excipients, or inactive ingredients found in pharmaceutical drugs.

A new fellowship, funded jointly by UCSF-Stanford CERSI and the U.S. Pharmacopeial Convention (USP), will support research into the inactive components of medications, which are known as excipients.

Giacomini named 2018 Volwiler Research Award recipient16

Mon Apr 16, 2018
Giacomini
Terrificshot13

Kathy Giacomini, PhD

Kathy Giacomini, PhD, has been named the 2018 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy.

Giacomini to receive North American Scientific Achievement Award17

Tue Sep 5, 2017
Giacomini
Terrificshot13

Kathy Giacomini, PhD

Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX).

Update from the Dean - March 201718

Wed Mar 15, 2017
Guglielmo
Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication...

Pages